Profile: Jeffrey Sherer

Jeffrey Sherer
Jeffrey T. Sherer, Pharm.D., MPH, BCPS, CGP
Clinical Associate Professor
Department of Clinical Sciences and Administration
UH College of Pharmacy
Texas Medical Center Campus, Room 330
1441 Moursund Street
Houston, TX 77030
832-842-8307
832-842-8383 (Fax)
JTSherer@uh.edu

Education

Bachelor of Science in Pharmacy (cum laude), The Ohio State University, Columbus, OH, 1994

Doctor of Pharmacy, Medical University of South Carolina, Charleston, SC, 1996

Residency in Pharmacy Practice with an Emphasis in Primary Care, Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, SC, 1997

Master of Public Health, University of Texas School of Public Health, Houston, TX, 2006. Thesis: Outcomes of Patients Receiving Zoledronic Acid or Pamidronate for Prevention of Skeletal-Related Events in Prostate Cancer.

Research Interests

Geriatrics, clinical epidemiology and evidence-based medicine, general medicine, primary care.

Awards & Honors

  • Recipient, Rho Chi Teaching Excellence Award, Beta Omicron Chapter, UH College of Pharmacy, 2011
  • Honorable Mention, Rho Chi Teaching Excellence Award, Beta Omicron Chapter, UH College of Pharmacy, 2010, 2009 and 2006
  • March 2010 Professor of the Month, UHCOP Doctor of Pharmacy Class of 2012
  • Co-MVP (Most Valuable Professor) Award, UHCOP Doctor of Pharmacy Class of 2009
  • Nominee, Faculty Teaching Excellence Award, UH College of Pharmacy, 2009 and 2006
  • Best Lecturer Award, UHCOP Doctor of Pharmacy Class of 2008
  • Faculty Preceptor of the Year, UH College of Pharmacy, 2007
  • Favorite Professor Award, UHCOP Doctor of Pharmacy Class of 2006
  • Nominee, John P. McGovern Outstanding Teacher Award, University of Texas School of Nursing, 2006-07

Courses

  • Introduction to Community Health
  • Cellular Life Sciences II
  • Pharmacy Practice IV
  • Pharmacodynamics II
  • Advanced Therapeutics I
  • Advanced Therapeutics II
  • Introduction to Pharmacy
  • Pharmacy and Geriatrics
  • Preceptor for Institutional Medicine clinical clerkship

Selected Peer-reviewed Publications

Bhowmik D, Aparasu RR, Rajan SS, Sherer JT, Ochoa-Perez M, Chen H. The utilization of psychopharmacological treatment and medication adherence among Medicaid enrolled children and adolescents with bipolar depression. J Affect Disord. 2013 Jun 6. doi:pii: S0165-0327(13)00335-2. 10.1016/j.jad.2013.04.034. [Epub ahead of print]

Chatterjee S, Mehta S, Sherer JT, Aparasu RR. Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey. Drugs Aging. 2010 Dec 1;27(12):987-97.

Nagar S, Sherer JT, Chen H, Aparasu RR. Extent of functional impairment in children and adolescents with depression. Curr Med Res Opin. 2010 Sep;26(9):2057-64.

Dasgupta A, Sansgiry SS, Sherer JT, Wallace D, Sikri S. Pharmacists’ Utilization and Interest in Usage of Personal Digital Assistants in Their Professional Responsibilities. Health Information and Libraries Journal. 2010;27:37-45.

Kamble P, Chen H, Sherer J, Aparasu R. Off-label Use of Second-generation Antipsychotic Agents among Elderly Nursing Home Residents in the United States. Psychiatric Services. 2010;61:130-6

Dasgupta A, Sansgiry SS, Sherer JT, Wallace D, Sikri S. Application of the Extended Technology Acceptance Model in Predicting Pharmacists’ Intention to Use Personal Digital Assistants. Journal of the American Pharmacists Association. 2009;49:792-6.

Kamble P, Chen H, Sherer JT, Aparasu RR. Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data. Drugs and Aging. 2009;26(6):483-92. 

Kamble P, Chen H, Sherer J, Aparasu RR. Antipsychotic Use Among Elderly Nursing Home Residents in the United States. American Journal of Geriatric Pharmacotherapy. 2008;6:187-97.

White J, Sherer J. Medication Use in Today’s Elderly Population. America’s Pharmacist. 2008;130(2):39-51. ACPE program number 207-000-08-002-H01-P

Sherer JT. Nonalzheimer’s Dementias. U.S. Pharmacist. 2007;32(12):26-34.

Sherer JT, Adamus AT. Outcomes of Patients Receiving Zoledronic Acid or Pamidronate for Prevention of Skeletal-Related Events in Prostate Cancer. Pharmacotherapy. 2007;27:207-17.

Kodityal S, Nguyen P, Kodityal A, Sherer J, Hursting MJ, Rice L. Argatroban for Suspected Heparin-Induced Thrombocytopenia: Contemporary Experience at a Large Teaching Hospital. Journal of Intensive Care Medicine. 2006;21:86-92.

Sherer JT. Pharmaceuticals in the Environment. American Journal of Health-System Pharmacy. 2006;63:174-8.

Other Publications & Formulary Monographs

Sherer JT. Adrenocorticoids: Clinical Significance. In: Lemke TL, Williams DA, eds. Foye’s Principles of Medicinal Chemistry. 6th ed. Baltimore: Lipincott Williams & Wilkins;2008:878.

Sherer JT. Cardiac Agents: Cardiac Glycosides, Antianginal, and Antiarrhythmic Drugs: Clinical Significance. In: Lemke TL, Williams DA, eds. Foye’s Principles of Medicinal Chemistry. 6th ed. Baltimore: Lipincott Williams & Wilkins;2008:699.

Sherer JT. Ask the Pharmacist. In: Howard A, ed. Branching Out. 2006;20(3):13. The Sturge-Weber Foundation, Mt. Freedom, NJ

Presentations & Abstracts

Nagar S, Aparasu RR, Chen H, Sherer J.  Health Care Expenditures in the Pediatric Population with Depression in the United States. Presented at the International Society of Pharmacoeconomics and Outcomes Research 15th Annual International Meeting, Atlanta, GA, May 2010

Nagar S, Aparasu RR, Chen H, Sherer J.  Functional Impairment in Children and Adolescents with Depression. Presented at the International Society of Pharmacoeconomics and Outcomes Research 15th Annual International Meeting, Atlanta, GA, May 2010

Mehta H, Patel J, Parikh R, Aparasu RR, Sherer J.  Ten-Year Trends in Prescription of Chronic Obstructive Pulmonary Disease Medication among Adults from 1996 to 2005. Presented at the International Society of Pharmacoeconomics and Outcomes Research 15th Annual International Meeting, Atlanta, GA, May 2010

Chatterjee S, Palli SR, Mehta S, Aprasu RR, Sherer JT.  Prevalence and Predictors of Anticholinergic Medication Use in Elderly Nursing Home Residents with Dementia. Presented at the International Society of Pharmacoeconomics and Outcomes Research 15th Annual International Meeting, Atlanta, GA, May 2010

Quadri S, Sherer JT, Birtcher KK, Rambin M, Jackson N, Salinas C, Patel T, Bernardo E.  The Role of Calcium-Magnesium Infusions in the Delay of Onset of Oxaliplatin-Associated Neuropathy. Presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL, December 2008

Gee JS, Sherer JT, Hayes JD, Greisinger A, Jackson N, Martinez DM, Salinas CC, Lee TR, Simpson L, Birtcher KK.  Primary Prevention Lipid Clinic with a Pharmacist on the Healthcare Team Attains LDL-C Goal More Often and Provides Additional Lipid Parameter Lowering After Usual Care. Presented at the Kelsey Research Foundation’s 9th Annual Health Services and Outcomes Research Conference, Houston, TX, December 2008 and the American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL, December 2008

Dasgupta A, Sansgiry SS, Tipton JA, Frost CP, Sherer JT.  Assessment of Workflow Parameters Associated with Barcode-Based Approach to Medication Administration. Presented at the Kelsey Research Foundation’s 9th Annual Health Services and Outcomes Research Conference, Houston, TX, December 2008 and the American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL, December 2008

Goel K, Sherer JT, Furman LM, Greisinger A, Nayak A, Mirzai-Tehane M, Rashid H, Mortazavi A, Birtcher KK.  Secondary Prevention Lipid Clinic Reaches LDL-C Goals More Often Than Usual Care for Very High-Risk Patients with Coronary Heart Disease and Risk Factors for the Metabolic Syndrome. Presented at the Kelsey Research Foundation’s 9th Annual Health Services and Outcomes Research Conference, Houston, TX, December 2008

Dasgupta A, Sansgiry SS, Sherer JT, Wallace D.  Assessing the Difference in Behavioral Adoption and Utilization Patterns of Personal Digital Assistants Between Hospital and Community Pharmacists. Presented at American Pharmacists Association Annual Meeting and Exposition, San Diego, CA, March 2008

Birtcher KK, Sherer JT, Wehmanen O, Brehm B, Greisinger, Rice G, Mirzai-Tehrane M, Rashid H, Mortazavi A.  Secondary Prevention Lipid Clinic Reaches LDL-C Goals More Often Than Usual Care for Very-high Risk Patients with Diabetes and Coronary Heart Disease. J Clin Lipidology.  2007;1:155-6. (abstract)

Putney D, Strapp E, Sherer J, Bernard D.  Safety and Efficacy of Managing Heparin Protocols with Anti-Xa Levels. Presented at the Weill Cornell Medical College, New York-Presbyterian Hospital, and The Methodist Hospital Quality 2010: Evolving Frontiers in Quality and Patient Safety Symposium, Houston, TX, March 2007  *Honored as symposium’s best poster*

Birtcher KK, Sherer JT, Wehmanen O, Brehm B, Greisinger, Rice G, Mirzai-Tehrane M, Rashid H, Mortazavi A.  Secondary Prevention Lipid Clinic Reaches LDL-C Goals More Often Than Usual Care for Very-High Risk Patients with Diabetes and Coronary Heart Disease. Presented at the Kelsey Research Foundation’s 7th Annual Health Services and Outcomes Research Conference, Houston, TX, November 2006 and at the National Lipid Association Annual Scientific Sessions, Scottsdale, AZ, June 2007

Sansgiry SS, Sikri S, Wallace D, Sherer J.  Attitude and Intention towards Adoption of Personal Digital Assistant (PDA) Technology by Pharmacists. Presented at American Association of Colleges of Pharmacy Annual Meeting, Cincinnati, OH, July 2005

Professional Service & Affiliations

  • Associate Editor, Tarascon Pocket Pharmacopoeia 2013
  • Preceptor, Nontraditional Doctor of Pharmacy Program, University of Colorado College of Pharmacy, Denver, CO. 2009 - present 
  • Member, Texas Medical Center Pharmacy Executives Council Clinical Subcommittee, Texas Medical Center, Houston, TX. 2008 - present
  • Member, 2008 Annual Meeting Focus Session Planning Committee, Geriatrics Practice and Research Network, American College of Clinical Pharmacy, Kansas City, MO. 2007-08
  • Member, Medical Advisory Board, Sturge-Weber Foundation, Mt. Freedom, N.J., 2006 - present
  • Member, Membership and Nominations Committee, Education & Training Practice and Research Network, American College of Clinical Pharmacy, Kansas City, MO., 2006 - present 
  • Member, Experiential Advisory Committee, University of Houston College of Pharmacy, Houston, TX, 2006 - present
  • Co-Advisor, Rho Chi Society Beta Omicron Chapter, University of Houston College of Pharmacy, Houston, TX, 2007 - present

Memberships

  • American Association of Colleges of Pharmacy
    • Pharmacy Practice Section
    • Curriculum Special Interest Group
    • Geriatric Pharmacy Special Interest Group
  • American College of Clinical Pharmacy
    • Adult Medicine Practice and Research Network
    • Ambulatory Care Practice and Research Network
    • Education and Training Practice and Research Network
    • Geriatrics Practice and Research Network
  • American Heart Association
    • Scientific Council on Clinical Cardiology
  • American Society of Health-System Pharmacists
    • Section of Clinical Specialists and Scientists
    • Section of Inpatient Care Practitioners
  • Gulf Coast Society of Health-System Pharmacists
    • Rho Chi Society
    • Texas Society of Health-System Pharmacists
  • Phi Lambda Sigma
  • Rho Chi Society
  • Texas Society of Health-System Pharmacists